Amitriptyline vs GON and SON Blocks in Migraine

NCT04750967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-09-08

No results posted yet for this study

Summary

Comparison of efficacy and safety of amitriptyline and nerve blocks

Conditions

Interventions

DRUG

Lidocaine 1% Injectable Solution

Repeated injections of lidocaine to greater occipital nerve and supraorbital nerve once a week for first four weeks then once a month for five months

DRUG

Amitriptyline

Amitriptyline 25 mg daily

Sponsors & Collaborators

  • Dr. Lutfi Kirdar Kartal Training and Research Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-03
Primary Completion
2022-01-01
Completion
2023-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750967 on ClinicalTrials.gov